Jeremy Cobb focuses on patent litigation and matters before the Patent Trial and Appeal Board with an emphasis on small molecule and biological patents. He is a senior associate focused on matters from case inception through trial and appeal. His experience includes arguing motions and claim construction, taking and defending expert and fact depositions, and overseeing case strategy and management. Mr. Cobb also has a deep understanding of pharmaceutical patent practice, including Hatch-Waxman litigation; regulatory exclusivity; patent term extensions; and pharmaceutical life cycle management.
Prior to becoming an attorney, Mr. Cobb designed and developed synthetic routes to active pharmaceutical ingredients and their intermediates at GlaxoSmithKline.
- J.D., University of North Carolina School of Law, 2012, high honors, Order of Coif
- M.S., Synthetic Organic Chemistry, University of Illinois at Urbana-Champaign, 2004
- B.S., Chemistry, Butler University, 2001,
- District of Columbia
- Federal Circuit